Kiniwa, Y., Nakamura, K., Mikoshiba, A., Ashida, A., Akiyama, Y., Morimoto, A., & Okuyama, R. (2021). Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation. BMC Cancer.
Chicago ZitierstilKiniwa, Yukiko, Kenta Nakamura, Asuka Mikoshiba, Atsuko Ashida, Yasuyuki Akiyama, Atsushi Morimoto, und Ryuhei Okuyama. "Usefulness of Monitoring Circulating Tumor Cells As a Therapeutic Biomarker in Melanoma With BRAF Mutation." BMC Cancer 2021.
MLA ZitierstilKiniwa, Yukiko, et al. "Usefulness of Monitoring Circulating Tumor Cells As a Therapeutic Biomarker in Melanoma With BRAF Mutation." BMC Cancer 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.